Brian T. Crum
2022
In 2022, Brian T. Crum earned a total compensation of $1.5M as Senior Vice President and General Counsel at Lexicon Pharmaceuticals, a 13% increase compared to previous year.
Compensation breakdown
| Bonus | $155,015 |
|---|---|
| Option Awards | $590,686 |
| Salary | $438,989 |
| Stock Awards | $250,528 |
| Other | $15,099 |
| Total | $1,450,317 |
Crum received $590.7K in option awards, accounting for 41% of the total pay in 2022.
Crum also received $155K in bonus, $439K in salary, $250.5K in stock awards and $15.1K in other compensation.
Rankings
In 2022, Brian T. Crum's compensation ranked 2,289th out of 5,760 executives tracked by ExecPay. In other words, Crum earned more than 60.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,289 out of 5,760 | 60th |
Division Manufacturing | 1,239 out of 3,136 | 61st |
Major group Chemicals And Allied Products | 550 out of 1,422 | 61st |
Industry group Drugs | 505 out of 1,323 | 62nd |
Industry Pharmaceutical Preparations | 368 out of 969 | 62nd |
Source: SEC filing on March 26, 2024.
Crum's colleagues
We found four more compensation records of executives who worked with Brian T. Crum at Lexicon Pharmaceuticals in 2022.
News
Lexicon Pharmaceuticals CEO Lonnel Coats' 2023 pay slips 1% to $4.1M
March 26, 2024
Lexicon Pharmaceuticals CEO Lonnel Coats' 2021 pay rises 2% to $3.9M
April 8, 2022
Lexicon Pharmaceuticals CEO Lonnel Coats' 2020 pay stays at $3.9M
March 19, 2021
Lexicon Pharmaceuticals CEO Lonnel Coats' 2019 pay jumps 24% to $3.9M
March 13, 2020
Lexicon Pharmaceuticals CEO Lonnel Coats' 2018 pay jumps 41% to $3.1M
March 14, 2019